# A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

> **NCT07512076** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 26 (estimated)

## Conditions studied

- Prostate Cancer Patients
- Elderly Patients
- Pharmacokinetic Study

## Interventions

- **DRUG:** Enzalutamide Dose Escalation
- **DRUG:** Standard of Care

## Key facts

- **NCT ID:** NCT07512076
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07512076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07512076, "A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT07512076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*